Reduces HbA1c: HbA1c is a measure of long-term blood sugar control, reflecting average blood glucose levels over the past few months
Here are the key conditions and situations where its use may pose risks: Personal or family history of medullary thyroid carcinoma (MTC): Semaglutide GLP-1 carries a boxed warning because it has been associated with thyroid C-cell tumors in animal studies
We use them to support healing after illness, promote lean muscle growth, regulate appetite, improve sleep, and more
When indicated, laboratory markers such as blood sugar trends, insulin sensitivity, or metabolic parameters may be reviewed to ensure the medication is supporting overall health
In the PIONEER program, oral semaglutide was associated with either stable or reduced fasting lipid levels compared with other treatments, with sustained reductions over time [6,7,8,9,10,11,12,13,14,15]